---
figid: PMC3483307__pone.0048091.g005
figtitle: 'Novel Genes and Pathways Modulated by Syndecan-1: Implications for the
  Proliferation and Cell-Cycle Regulation of Malignant Mesothelioma Cells'
organisms:
- Homo sapiens
- Mus musculus
- Armoracia rusticana
- Hepatitis B virus
pmcid: PMC3483307
filename: pone.0048091.g005.jpg
figlink: /pmc/articles/PMC3483307/figure/pone-0048091-g005/
number: F5
caption: 'The figure summarizes the most important findings related to syndecan-1
  overexpression. Green, red and gray boxes respectively show downregulated, upregulated
  and unaffected genes by syndecan-1 overexpression. Color intensity is proportional
  with fold change (FC): dark red and dark green correspond to a FC≥9, red and green
  correspond to a FC<9 and FC≥2, light red and green correspond to a FC<2 and FC≥1.5.
  Syndecan-1 acts on several growth-factor related pathways at multiple levels as
  illustrated by the TGF-beta pathway. The elements of JAK-STAT pathway are enhanced.
  The expression of growth factor receptors is mainly overexpressed. The MAPK cascade
  is perturbed at different points, receiving both direct and indirect signals, collectively
  leading to alterations of various transcription factors and cellular responses such
  as proliferation and cell-cycle regulation.'
papertitle: 'Novel Genes and Pathways Modulated by Syndecan-1: Implications for the
  Proliferation and Cell-Cycle Regulation of Malignant Mesothelioma Cells.'
reftext: Tünde Szatmári, et al. PLoS One. 2012;7(10):e48091.
year: '2012'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9524623
figid_alias: PMC3483307__F5
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
redirect_from: /figures/PMC3483307__F5
ndex: 91065531-def0-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3483307__pone.0048091.g005.html
  '@type': Dataset
  description: 'The figure summarizes the most important findings related to syndecan-1
    overexpression. Green, red and gray boxes respectively show downregulated, upregulated
    and unaffected genes by syndecan-1 overexpression. Color intensity is proportional
    with fold change (FC): dark red and dark green correspond to a FC≥9, red and green
    correspond to a FC<9 and FC≥2, light red and green correspond to a FC<2 and FC≥1.5.
    Syndecan-1 acts on several growth-factor related pathways at multiple levels as
    illustrated by the TGF-beta pathway. The elements of JAK-STAT pathway are enhanced.
    The expression of growth factor receptors is mainly overexpressed. The MAPK cascade
    is perturbed at different points, receiving both direct and indirect signals,
    collectively leading to alterations of various transcription factors and cellular
    responses such as proliferation and cell-cycle regulation.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Dcn
  - Tgfbr1
  - Lum
  - Tgfa
  - Smad2
  - Smad3
  - Cdkn1a
  - Slc12a9
  - Nsg1
  - Tpt1
  - Tceal1
  - Cdk2
  - Bgn
  - Map2k3
  - Crk
  - Grap2
  - Syp
  - Mapk14
  - Ahsa1
  - Sulf1
  - pk
  - Relb
  - Hs2st1
  - Nfkb1
  - Nfkbia
  - Madd
  - Rasgrp1
  - Ets1
  - Vegfa
  - Map2k1
  - Mapk3
  - ras
  - Hras
  - Kras
  - Rem1
  - Grb2
  - Myc
  - Nol3
  - Egf
  - Egfr
  - Zhx2
  - Map2k2
  - Mapk1
  - Pdgfrb
  - Fos
  - Akt1
  - Akt2
  - Dusp6
  - Dusp22
  - Jund
  - Map2k4
  - Mapk8
  - Jun
  - Ltb
  - Pkm
  - Prickle3
  - Map2k7
  - CCND1
  - CCND2
  - CCND3
  - DCN
  - TGFBR1
  - LUM
  - TGFA
  - CCNE1
  - CCNE2
  - TGFBR2
  - SMAD2
  - SMAD3
  - CDKN1A
  - SLC12A9
  - TCEAL1
  - NSG1
  - H3P16
  - CDK2
  - BGN
  - MAP2K3
  - CRK
  - MAPK14
  - MAPK1
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - SULF1
  - RELB
  - HS2ST1
  - NFKB1
  - RELA
  - REL
  - NFKB2
  - NFKBIA
  - MADD
  - FGF1
  - FGF2
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FGF10
  - FGF11
  - FGF12
  - FGF13
  - FGF14
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGFR1
  - FGFR2
  - FGFR3
  - FGFR4
  - FGFRL1
  - RASGRP1
  - RASGRP2
  - RASGRP3
  - RASGRP4
  - ETS1
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - KDR
  - FLT1
  - FLT4
  - MAP2K1
  - MAPK3
  - XYLT2
  - SOS1
  - SOS2
  - KRAS
  - HRAS
  - NRAS
  - GRB2
  - MYC
  - EGF
  - EGFR
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAP2K2
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PDGFRB
  - PDGFRA
  - FOS
  - FOSB
  - FOSL1
  - FOSL2
  - AKT1
  - PTK2B
  - DUSP6
  - DUSP22
  - JUND
  - MAP2K4
  - MAPK8
  - MAPK9
  - MAPK10
  - JUN
  - CD74
  - ING1
  - LTB
  - CENPK
  - PRICKLE3
  - PKM
  - MAP2K7
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - SOAT1
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
